Literature DB >> 20109110

Posttraumatic stress disorder and dyslipidemia: previous research and novel findings from patients with PTSD caused by myocardial infarction.

Roland Von Känel1, Bernd Kraemer, Hugo Saner, Jean-Paul Schmid, Chiara C Abbas, Stefan Begré.   

Abstract

OBJECTIVES: Based on a brief systematic review suggesting dyslipidemia in posttraumatic stress disorder (PTSD), we studied, for the first time, levels of blood lipids in patients with a DSM-IV diagnosis of PTSD caused by myocardial infarction (MI).
METHODS: Study participants were eight patients with full PTSD, eight patients with subsyndromal PTSD, and 31 patients with no PTSD who were diagnosed using the Clinician-Administered PTSD Scale (CAPS) interview after a mean of 32+/-8 months after MI. Levels of total cholesterol, low-density lipoprotein-cholesterol, triglycerides, and high-density lipoprotein-cholesterol (HDL-C) were determined in plasma.
RESULTS: Patients with full PTSD had lower HDL-C than patients with subsyndromal PTSD (P = 0.044) and those with no PTSD (P = 0.014) controlling for sex, body mass index, and statin equivalent dosage. Moreover, HDL-C levels were inversely associated with PTSD total symptoms (r = -0.33, P = 0.027), re-experiencing symptoms (r = -0.32, P = 0.036), and avoidance symptoms (r = -0.34, P = 0.025). There were no significant associations of PTSD diagnostic status and symptomatology with the three other lipid measures.
CONCLUSION: Chronic PTSD caused by MI was associated with lower plasma levels of HDL-C. The finding concurs with the notion of dyslipidemia partially underlying the atherosclerotic risk in individuals with PTSD caused by different types of trauma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109110     DOI: 10.3109/15622970903449846

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  6 in total

1.  Allostatic load and the cannabinoid system: implications for the treatment of physiological abnormalities in post-traumatic stress disorder (PTSD).

Authors:  James B Lohr; Hang Chang; Michelle Sexton; Barton W Palmer
Journal:  CNS Spectr       Date:  2019-07-15       Impact factor: 3.790

2.  Effect of Early Psychological Counseling for the Prevention of Posttraumatic Stress Induced by Acute Coronary Syndrome at Long-Term Follow-Up.

Authors:  Mary Princip; Aju P Pazhenkottil; Jürgen Barth; Ulrich Schnyder; Hansjörg Znoj; Jean-Paul Schmid; Rebecca E Langraf-Meister; Roland von Känel; Katharina Ledermann
Journal:  Front Psychiatry       Date:  2022-05-30       Impact factor: 5.435

3.  CHRONIC UNPREDICTABLE MILD STRESS PROGRESSIVELY DISTURBS GLUCOSE METABOLISM AND APPETITE HORMONES IN RATS.

Authors:  A L López López; M C Escobar Villanueva; M Brianza Padilla; H Bonilla Jaime; F J Alarcón Aguilar
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Jan-Mar       Impact factor: 0.877

4.  Sex-specific chronic stress response at the level of adrenal gland modified sexual hormone and leptin receptors.

Authors:  Marta Balog; Milan Miljanović; Senka Blažetić; Irena Labak; Vedrana Ivić; Barbara Viljetić; Attila Borbely; Zoltán Papp; Robert Blažeković; Sandor G Vari; Miklós Fagyas; Marija Heffer
Journal:  Croat Med J       Date:  2015-04       Impact factor: 1.351

5.  Myocardial Infarction - Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: study protocol for a randomized controlled trial.

Authors:  Rebecca Meister; Mary Princip; Jean-Paul Schmid; Ulrich Schnyder; Jürgen Barth; Hansjörg Znoj; Claudia Herbert; Roland von Känel
Journal:  Trials       Date:  2013-10-11       Impact factor: 2.279

6.  Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder.

Authors:  Lucija Tudor; Marcela Konjevod; Matea Nikolac Perkovic; Dubravka Svob Strac; Gordana Nedic Erjavec; Suzana Uzun; Oliver Kozumplik; Marina Sagud; Zrnka Kovacic Petrovic; Nela Pivac
Journal:  Front Psychiatry       Date:  2018-11-27       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.